for Journals by Title or ISSN
for Articles by Keywords
help

Publisher: Horizon Research Publishing   (Total: 54 journals)   [Sort by number of followers]

Showing 1 - 54 of 54 Journals sorted alphabetically
Advances in Diabetes and Metabolism     Open Access   (Followers: 23)
Advances in Economics and Business     Open Access   (Followers: 16)
Advances in Energy and Power     Open Access   (Followers: 16)
Advances in Pharmacology and Pharmacy     Open Access   (Followers: 6)
Advances in Signal Processing     Open Access   (Followers: 13)
Advances in Zoology and Botany     Open Access  
Bioengineering and Bioscience     Open Access   (Followers: 1)
Cancer and Oncology Research     Open Access   (Followers: 10)
Chemical and Materials Engineering     Open Access   (Followers: 20)
Civil Engineering and Architecture     Open Access   (Followers: 24)
Computational Research     Open Access   (Followers: 1)
Computer Science and Information Technology     Open Access   (Followers: 13)
Energy and Environmental Engineering     Open Access   (Followers: 7)
Environment and Ecology Research     Open Access   (Followers: 8)
Food Science and Technology     Open Access   (Followers: 3)
Immunology and Infectious Diseases     Open Access   (Followers: 9)
Intl. J. of Biochemistry and Biophysics     Open Access   (Followers: 1)
Intl. J. of Cardiovascular and Cerebrovascular Disease     Open Access   (Followers: 2)
Intl. J. of Neuroscience and Behavioral Science     Open Access   (Followers: 1)
Linguistics and Literature Studies     Open Access   (Followers: 4)
Manufacturing Science and Technology     Open Access   (Followers: 3)
Mathematics and Statistics     Open Access   (Followers: 5)
Nanoscience and Nanoengineering     Open Access   (Followers: 1)
Natural Resources and Conservation     Open Access   (Followers: 6)
Nursing and Health     Open Access   (Followers: 4)
Open J. of Dentistry and Oral Medicine     Open Access   (Followers: 1)
Sociology and Anthropology     Open Access   (Followers: 5)
Sport and Art     Open Access   (Followers: 1)
Universal J. of Accounting and Finance     Open Access   (Followers: 3)
Universal J. of Agricultural Research     Open Access   (Followers: 1)
Universal J. of Applied Mathematics     Open Access   (Followers: 5)
Universal J. of Applied Science     Open Access   (Followers: 2)
Universal J. of Biomedical Engineering     Open Access  
Universal J. of Chemistry     Open Access   (Followers: 1)
Universal J. of Clinical Medicine     Open Access  
Universal J. of Communications and Network     Open Access   (Followers: 1)
Universal J. of Computational Mathematics     Open Access   (Followers: 5)
Universal J. of Control and Automation     Open Access   (Followers: 4)
Universal J. of Educational Research     Open Access   (Followers: 1)
Universal J. of Electrical and Electronic Engineering     Open Access   (Followers: 6)
Universal J. of Engineering Science     Open Access   (Followers: 2)
Universal J. of Food and Nutrition Science     Open Access   (Followers: 5)
Universal J. of Geoscience     Open Access   (Followers: 4)
Universal J. of Industrial and Business Management     Open Access   (Followers: 1)
Universal J. of Management     Open Access   (Followers: 2)
Universal J. of Materials Science     Open Access   (Followers: 3)
Universal J. of Mechanical Engineering     Open Access   (Followers: 15)
Universal J. of Medical Science     Open Access  
Universal J. of Microbiology Research     Open Access  
Universal J. of Physics and Application     Open Access   (Followers: 2)
Universal J. of Plant Science     Open Access  
Universal J. of Psychology     Open Access   (Followers: 3)
Universal J. of Public Health     Open Access   (Followers: 2)
World J. of Computer Application and Technology     Open Access   (Followers: 3)
Journal Cover
International Journal of Cardiovascular and Cerebrovascular Disease
Number of Followers: 2  

  This is an Open Access Journal Open Access journal
ISSN (Print) 2331-9887 - ISSN (Online) 2331-9895
Published by Horizon Research Publishing Homepage  [54 journals]
  • Correlation between Cystatin C and Pulmonary Hypertension in Patients with
           Idiopathic Pulmonary Fibrosis

    • Abstract: Publication date:  Sep 2017
      Source:International Journal of Cardiovascular and Cerebrovascular Disease  Volume  5  Number  3  Yong-quan, Huang   Yin, Huang   Yuling, Wang   Ting, Xie   and Junyong, Han   Objective: To analyze the relationship between Cystatin C and pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis. Methods: A clinical cohort of sixty-eight idiopathic pulmonary fibrosis patients and forty normal individuals was established. All the cases were obtained from department of respiratory in the fifth affiliated hospital of Sun Yat-Sen University from May 2009 to May 2017. Data including basic information, Cystatin C, echocardiography parameters of each patients were recorded. Then the serum Cystatin C between the two groups was compared. The correlation between Cystatin C and pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis was evaluated. Results: The serum Cystatin C level in IPF patients was observed higher than that in normal cases with significant difference (P<0.001). Patients with increased level of serum Cystatin C had statistical significant higher (P<0.05) Cystatin C and Echocardiography parameters including RAD, RVDd, PA, velocity of TR, and pulmonary arterial. The Cystatin C serum concentrations were positively correlated with RAD, RVDD, velocity of TR, and pulmonary arterial pressure. Multiple linear regression (stepwise method) analysis showed that the serum Cystatin C was positively correlated with pulmonary arterial pressure with the maximum impact, suggesting that the concentration of serum Cystatin C was one significant factor in PH of PIF patients(P
      PubDate: Sep 2017
       
  • The Spectrum and Distribution of Imaging Findings at Coronary Computed
           Tomography Angiogram in Patients Suspected to Have Coronary Artery
           Disease: A Cross-sectional Study Carried Out at Plaza Imaging Solutions in
           Nairobi, Kenya

    • Abstract: Publication date:  Jun 2017
      Source:International Journal of Cardiovascular and Cerebrovascular Disease  Volume  5  Number  2  Omamo Eunice A.   Background: Coronary CT angiography (CCTA) has in the recent past evolved rapidly due to development of sophisticated multi detector row CT (MDCT). The cardinal indication for CCTA is the evaluation of suspected or known coronary artery disease (CAD). Coronary CTA imaging can detect and characterize atherosclerotic plaques. In addition, it can confirm or exclude luminal stenosis. Other applications include identification and assessment of variations in coronary arterial circulation patterns, evaluation of isolated anomalous coronary vessels, by-pass grafts, coronary stents patency and assessment of left ventricular function. Study objective: This study was set to determine the spectrum, pattern and distribution of imaging findings at Coronary CT angiograms as detected by a 320 row MDCT in patients who had undergone coronary CTA. Study design: A cross sectional study. Setting: Plaza Imaging Solutions Limited, Nairobi, Kenya. Subjects: Patients imaged at Plaza Imaging Solutions Limited over a period of 6 months. Materials and methods: Study subjects: Consecutive patients referred for coronary CTA at Plaza Imaging Solutions Limited and met the inclusion criteria. Ethical considerations: Ethical approval and clearance was obtained from the KNH-UON Ethics Review Board. Written and verbal consent was obtained from the participating persons and/or their kin Tools: A two-part data collection form was used to manually record all the relevant data. The information included socio-demographics, clinical and imaging finding of Coronary CTA. A low dose calcium scan and a standard coronary CTA were performed. Each Coronary CTA study was reviewed by a radiologist together with the researcher. Statistical analysis: Data analysis was performed using the Statistical Package for Social Sciences (SPSS) employing relevant statistical tests. The results were presented in form of frequency tables, graphs and charts and discussed accordingly. Statistical significance was set at p < 0.05. Results: During the six-month period, 38 out of a total of 42 scanned patients were recruited into the study. The age distribution ranged from 21 to 89 years with a mean age of 56 years (SD 14.8-19.2). Male to female ratio was 5:4. Chest pain (angina) accounted for the commonest indication for imaging at 63.2%. Risk factors of hypertension and diabetes mellitus were noted in 39.5% of patients. More males reported a co- morbid state of diabetes mellitus (DM-Type II) while more females 50% had hypertension. Overall there were more patients with abnormal scans at 76% than the normal. Atherosclerotic coronary plaque lesions were the most commonly encountered abnormality accounting for 93.1%. The predominant plaque type was the non-calcified plaque seen in 50% of males and 61.5% of females. The total calcium scores (Agatston) ranged from 0 to 242. Calcified plaques were predominantly on the left anterior descending coronary artery (LAD), while the non-calcified plaques were significant on the right coronary artery (RCA). Conclusion: The study demonstrated common occurrence of coronary atherosclerotic plaques in the older age group with lower incidence seen in younger individuals aged less than 40 years of age. It also demonstrated the wide spectrum of luminal effect caused by the atherosclerotic plaques. Furthermore, it demonstrated the paucity of calcified atherosclerotic plaques amongst the local population undergoing coronary CTA highlighting the insignificant nature of coronary calcium score in this setting. Recommendations: Based on the findings and conclusions of this study, a recommendation is made for coronary CTA to be performed in the older age group of> 55 years of age with symptomatic features of ischemic heart disease. Coronary calcium scoring is not necessary in individuals undergoing coronary CTA in this setting (black race) as no correlation is found between total calcium score and atherosclerotic disease burden.
      PubDate: Jun 2017
       
  • Cardio Protective Action of Cilostazol, Milrinone and Their Combination
           over Isoproterenol Induced Myocardial Infarction in Wistar Rats

    • Abstract: Publication date:  Feb 2017
      Source:International Journal of Cardiovascular and Cerebrovascular Disease  Volume  5  Number  1  Prashant Kumar Dhakad   Pramod Kumar Sharma   Sokindra Kumar   Ashish Kr. Sharma   Raghav Mishra   and Aditya Dixit   The cardio protective action of cilostazol, milrinone and their combination effect on myocardial infarction induced by isoproterenol subjected to Wistar rats was done by studying various parameters - heart rate, % infarct size change, LDH level, CPKMB level, ECG pattern. In the following research work effect of synthetic drugs cilostazol, milrinone and their combined effect were studied over various biochemical and cardiac parameters. Isoproterenol was used in inducing myocardial infarction to Wistar rats. Isoproterenol (15 mg/100g) administration, causes an increased levels of biochemical markers-lactate dehydrogenase (2546.25±1.38), creatine phosphokinase (1485.5±.80) in serum of rats indicating potential action of isoproterenol on myocardium. Due to necrosis of myocardium a marked increase of these enzymes was seen in blood. A significant decrease in heart rate (262±.96) in isoproterenol treated rats was observed. Infarct size in ISO group rats (41%±.008) increased to certain extent with promiscuous yellow colored non-viable cells visible indicating infarction. Statistical analysis done by one-way ANOVA followed by the Dunnett's multiple comparison test where ISO control group compared with other groups, p value < 0.001 indicating extremely significant results. The present study demonstrated pharmacological benefits of combination dose of cilostazol, milrinone as evidenced by improvement in heart rate, Lactate dehydrogenase level, Creatine phosphokinase MB level, Electrocardiogram pattern, % infarct size.
      PubDate: Feb 2017
       
  • Evaluation of Antihypertensive Activity of Aqueous and Ethylic Alcohol
           Extracts of Stem Bark of Xylopia villosa Chipp (Annonaceae)

    • Abstract: Publication date:  Feb 2017
      Source:International Journal of Cardiovascular and Cerebrovascular Disease  Volume  5  Number  1  Kouame Yao Yves   Okpekon Aboua Timothée   and Yapi Houphouët Félix   This study aims to evaluate Antihypertensive activity of aqueous and ethanolic extracts of Xylopia villosa stem bark. The induction of hypertension was made with adrenaline on albino rats of wistar strain. Treatments of hypertensive rats with aqueous and ethanolic extracts of Xylopia villosa at doses of 100 and 200 mg/kg bw and Atenolol (the reference molecule) at doses of 10 and 20 mg/kg bw have normalized cardiovascular parameters such as systolic blood pressure, diastolic blood pressure and heart rate. However, these doses all increased the blood concentration of Na+ of hypertensive rats. Only treatments with aqueous and ethanolic extracts at a dose of 200mg/kg bw were able to bring blood concentration in K+ of hypertensive rats to a concentration equivalent to that of normotensive rats.
      PubDate: Feb 2017
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.235.48.106
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-